Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  recombinant tumor necrosis factor family protein
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 68 for your search:
Start Over
Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01843, Z0020, ACOSOG-Z0020, CDR0000066929, NCI-03-C-0137, U10CA076001, NCT00003789
Phase III Randomized Study of Hyperthermic Isolated Limb Perfusion with L-PAM vs L-PAM/TNF/IFN-G in Patients with Stage IIIA/IIIAB Malignant Melanoma Confined to an Extremity
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UPCC-3695, NCI-92-C-0105H, NCI-T91-0238D, T91-0238
Phase I/II Immunotherapy with rTNF in Patients with Metastatic Renal Cell Carcinoma and Metastatic Melanoma
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to physiologic 70
Sponsor:
Protocol IDs: GENENTECH-MDA-86049, NCI-V86-0137
Phase I/II Study of In Vivo-Primed TIL in Combination with IFN-A/IL-2 in Patients with Metastatic Renal Cell Carcinoma
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: UCLA-9102071, UCLA-UO-91-1, NCI-B91-0006, B91-0006
Phase I/II Study of Hyperthermic Isolated Hepatic Perfusion With Tumor Necrosis Factor (TNF) and Melphalan (L-PAM) for Primary or Metastatic Hepatic Cancer (Summary Last Modified 09/97)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-93-C-0105M, NCI-T94-0129N, T94-0129
Phase II Randomized Study of Isolated Limb Perfusion Using Melphalan With or Without Tumor Necrosis Factor in Patients with Unresectable High Grade Soft Tissue Sarcomas of the Extremity
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor: NCI
Protocol IDs: NCI-99-C-0145, NCI-T99-0067, NCT00019968
Phase II Study of Recombinant Tumor Necrosis Factor in Patients with Low-Grade Lymphoma (Summary Last Modified 09/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: LAC-USC-13NHL871, NCI-T87-0144D, T87-0144
Phase II Study of rTNF in Patients with Metastatic Renal Cell Carcinoma (Summary Last Modified 06/89)
Phase: Phase II
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: CAN-NCIC-IND38, NCI-T87-0291O, T87-0291, IND38
Phase II Study of TNF in Selected Patients with Advanced Small Cell or non-Small Cell Lung Cancer (Summary Last Modified 03/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to physiologic 70
Sponsor: NCI
Protocol IDs: MAYO-872601, NCI-T87-0249C, T87-0249
Phase II Study of TNF in Patients with Disseminated Malignant Melanoma (Summary Last Modified 04/88)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to physiologic 70
Sponsor: NCI
Protocol IDs: MAYO-877003, NCI-T87-0250C, T87-0250
Phase II Study of TNF in Patients with Recurrent or Metastatic Squamous Cell Carcinomas of the Head and Neck (Summary Last Modified 05/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: UMCC-8728, NCI-T88-0027C, T88-0027
Phase II Study of rTNF in Patients with Metastatic Colorectal Adenocarcinoma (Summary Last Modified 11/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8743
Phase II Study of rTNF in Patients with Advanced Endometrial Cancer (Summary Last Modified 05/89)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8752
Phase II Study of rTNF in Patients with Pancreatic Adenocarcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8755
Phase II Study of rTNF in Patients with Gastric Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8760
Phase II Study of Recombinant Tumor Necrosis Factor in Patients with Metastatic Sarcoma (Summary Last Modified 05/89)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8742
Phase II Study of Recombinant Tumor Necrosis Factor in Patients with Refractory Multiple Myeloma (Summary Last Modified 11/88)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8744
Phase II Study of Recombinant TNF in Patients with Advanced Soft Tissue Sarcoma (Summary Last Modified 08/88)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to physiologic 70
Sponsor:
Protocol IDs: UCLA-8802034, NCI-V88-0369
Phase II Study of rTNF in Patients with Refractory Carcinoma of the Breast (Summary Last Modified 07/89)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8741
Phase II Trial of rTNF in Patients with non-Small Cell Lung Carcinoma (Summary Last Modified 02/89)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UMCC-8712, NCI-T87-0275C, T87-0275
Start Over